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ABSTRACT The functional effects of calmodulin (CaM) on single cardiac sarcoplasmic reticulum Ca21 release channels
(ryanodine receptors) (RyR2s) were determined in the presence of two endogenous channel effectors, MgATP and reduced
glutathione, using the planar lipid bilayer method. Single-channel activities, number of events, and open and close times were
determined at varying cytosolic Ca21 concentrations. CaM reduced channel open probability at\10 mM Ca21 by decreasing
channel events and mean open times and increasing mean close times. At[10 mM Ca21, CaM was less effective in inhibiting
RyR2. CaM decreased mean open times but increased channel events, without signiﬁcantly affecting mean close times. A
series of voltage pulses was applied to the bilayer from 150 to –50 mV and from –50 mV to 150 mV to rapidly increase and
decrease open channel-mediated sarcoplasmic reticulum lumenal to cytosolic Ca21 ﬂuxes. CaM decreased the duration of the
open events after the voltage switch from –50 mV to 150 mV. In parallel experiments, a Ca21-insensitive calmodulin mutant
was without effect on RyR2 activity. The results are discussed in terms of a possible role of CaM in the termination of cardiac
sarcoplasmic reticulum Ca21 release.
INTRODUCTION
Cardiac muscle contracts during an action potential when the
inﬂux of extracellular Ca21 triggers the release of Ca21 from
an intracellular Ca21-storing organelle, the sarcoplasmic re-
ticulum (SR). Ca21 entry through voltage- and dihydropy-
ridine-sensitive L-type Ca21 channels (DHPRs) in the
surface membrane and transverse tubule opens closely
apposed SR Ca21 release channels (ryanodine receptors)
(RyR2s), a process termed calcium-induced calcium release
(Fabiato, 1985). Ca21-gated Ca21 release through the RyR2
ion channel is modulated by allosteric effectors such as
MgATP, inhibitors such as Mg21, redox active molecules,
protein kinases and phosphatases, and calmodulin (CaM)
(Franzini-Armstrong and Protasi, 1997; Fill and Copello,
2002; Meissner, 2002).
CaM is a ubiquitous cytosolic Ca21-binding protein that
modulates cellular events through calmodulin-dependent
protein kinases or by direct binding of CaM (Rhoads and
Friedberg, 1997). Direct binding of CaM inhibits the rya-
nodine receptors (Balshaw et al., 2002). RyR2 has one high-
afﬁnity binding domain that is shared by the Ca21-free and
Ca21-bound forms of CaM (Yamaguchi et al., 2003). Bind-
ing and release of the Ca21-free and Ca21-bound forms of
CaM occur within seconds to minutes (Balshaw et al., 2001).
It is thus unlikely that CaM regulates cardiac SR Ca21
release by binding to or dissociating from the RyR2 during
a cardiac action potential.
An unresolved question is how Ca21 induced Ca21
release from the SR is terminated during an action potential.
During a cardiac action potential, Ca21 ions entering the cell
via the L-type Ca21 channel trigger the release of massive
amounts of Ca21 from the SR via the RyR2 and the release
of Ca21 triggers further Ca21 release. Such a high-gain,
positive feedback system is potentially unstable, resulting in
a none-or-all response, in disagreement with experimental
evidence of graded Ca21 release (Bassani et al., 1995;
Negretti et al., 1995; Chen et al., 1998). Proposed mech-
anisms for terminating SR Ca21 release include Ca21-
induced inactivation of RyR2 (Fabiato, 1985), depletion
of SR Ca21 (Luo and Rudy, 1994), and the simultaneous
closing of all active RyRs in a release unit to reduce the
Ca21 concentration to a subthreshold activation level (Stern,
1992; Sobie et al., 2002).
In this study we tested the hypothesis that CaM facilitates
the termination of cardiac SR Ca21 release by altering the
kinetics of Ca21-gated RyR2 activity. The functional effects
of CaM on the RyR2 ion channel were examined using the
planar lipid bilayer technique. Single-channel activities and
the kinetics of channel opening and closing were determined
at varying cytosolic Ca21 concentrations in the absence and
presence of CaM. A voltage-pulse protocol was used to
determine the effects of CaMonRyR2s that were activated by
open channel-mediated SR lumenal to cytosolic Ca21 ﬂuxes.
The results show that CaM inhibits RyR2 ion channel activity
in a Ca21-dependentmanner bymodifying the transition rates
of the open-to-close and close-to-open channel states.
MATERIALS AND METHODS
Materials
Phospholipids were obtained from Avanti Polar Lipids (Alabaster, AL). The
cDNA encoding CaM was kindly provided by Dr. Claude Klee at the
National Institutes of Health, Bethesda, MD. The CaMD1234A cDNA was
a generous gift of Dr. John Adelman at Oregon Health Sciences University,
Portland, OR. CaM and the non-Ca21 binding CaM mutant were expressed
in Escherichia coli and puriﬁed as described (Balshaw et al., 2001). All other
chemicals were of analytical grade.
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Preparation of SR vesicles and puriﬁcation
of the RyR2
Canine cardiac SR vesicle fractions enriched in RyR2 were prepared in the
presence of protease inhibitors (Balshaw et al., 2001). Endogenous CaMwas
removed by incubating SR vesicles for 30 min at 248C with 1 mM myosin
light chain kinase-derived calmodulin binding peptide in 100 mM Ca21
followed by centrifugation through 15% sucrose to remove complexed and
free peptide (Balshaw et al., 2001). The 3-[(3-cholamidopropyl)dimethyl-
ammonio]-1-propanesulfonate (CHAPS)-solubilized 30S RyR2 complexes
were isolated by rate density centrifugation and reconstituted into proteo-
liposomes by removal of CHAPS by dialysis (Lee et al., 1994).
Single-channel measurements
Single-channel measurements were performed by fusing cardiac SR vesicles
or proteoliposomes containing the puriﬁed RyR2 with Mueller-Rudin type
bilayers containing phosphatidylethanolamine, phosphatidylserine, and
phosphatidylcholine in the ratio 5:3:2 (25 mg of phospholipid per ml
n-decane) (Xu and Meissner, 1998). The side of the bilayer to which the SR
vesicles or proteoliposomes were added was deﬁned as the cis side. The
trans side was deﬁned as ground. Single channels were recorded in solutions
containing 0.25 M CsCH3SO3, 10 mM Cs-Hepes, pH 7.3 (SR vesicles), or
0.25 M KCl, 20 mM KHepes, pH 7.4 (puriﬁed RyR2) on both sides of the
bilayer and additions as indicated. Electrical signals were ﬁltered at 2 kHz
(Figs. 1, 3 and 4) or 300 Hz (Fig. 2), digitized at 10 kHz, and analyzed as
described (Xu andMeissner, 1998). Free Ca21 concentrations were obtained
by including 0.5–1 mM EGTA and levels of Ca21 as determined by
a computer program (Schoenmakers et al., 1992). Free Ca21 concentrations
of $1 mM were veriﬁed with the use of a Ca21 selective electrode
(detectION, Philadelphia, PA) and those of\1 mM using Fluo-3.
In voltage pulse experiments, 500 mM trans Ca21 and 0.1 mM cis Ca21
and a series of voltage pulses were used to rapidly increase or decrease open
channel-mediated lumenal-to-cytosolic Ca21 ﬂuxes (Xu and Meissner,
1998). Large capacitance currents occurring during voltage pulses were
FIGURE 1 Effect of calmodulin on
single cardiac SR Ca21 release channel
with Cs1 as current carrier. Cardiac SR
vesicles were fused with a lipid bilayer
and single-channel currents were recor-
ded at 35 mV (downward deﬂection
from close levels, c--) in symmetric
0.25 M CsCH3SO3, 10 mM Cs-Hepes,
pH 7.3 media containing 2 mM (A) or
100 mM (B) free cytosolic Ca21, 5 mM
cytosolic GSH, and 5 mM MgATP in
the absence (top traces) and presence
(bottom traces) of 1 mM cytosolic
CaM. Trans (SR lumenal) Ca21 was 2
mM. (C) Effect of CaM on cardiac
Ca21 release channel activity at the
shown cytosolic Ca21 concentrations
without () or with (m) 1 mM CaM.
Data are the mean 6 SE of 5–16
experiments. (D) Effect of CaM on
single-channel kinetic parameters at
0.15–100 mM cytosolic Ca21. Data
are the mean 6 SE of 3–11 experi-
ments. * and ** signiﬁcantly different
from controls (CaM) at p\ 0.05 and
p\ 0.001, respectively.
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corrected by subtracting those of blank (no channel openings) episodes and
‘‘nulled out’’ using an Axopatch 200B ampliﬁer (Axon Instruments, Foster
City, CA) with an integrative headstage.
Data analysis
Results are given as mean6 SE. Signiﬁcance of differences in the data was
analyzed with Student’s t-test. Differences were regarded to be statistically
signiﬁcant at p\ 0.05.
RESULTS
CaM inhibition of single RyR2 channels
activated by cytosolic Ca21
Functional effects of CaM on the cardiac Ca21 release
channel (RyR2) were examined using the planar lipid bilayer
method. Cardiac SR vesicles enriched in RyR2 were fused
with the lipid bilayer. Single-channel activities and the
kinetics of channel opening and closing were determined at
varying cytosolic Ca21 concentrations in the absence and
presence of a maximally inhibiting concentration of 1 mM
CaM (Balshaw et al., 2001) under steady-state conditions.
Fig. 1 A shows a representative single RyR2 ion channel
recording in the absence (upper trace) and presence (lower
trace) of 1 mM CaM at 2 mM free Ca21 in the cis (cytosolic)
bilayer chamber. The free trans (SR lumenal) Ca21 con-
centration was 2 mM. Channels were recorded in a cesium
methanesulfonate buffer to minimize K1 and Cl channel
activities also present in the SR (Meissner, 1983). Use of
Cs1 rather than Ca21 as a current carrier allowed tight control
of RyR2 by cytosolic Ca21. Experiments were performed in
the presence of two endogenous effector molecules, MgATP
and reduced glutathione (GSH), that affect regulation of
RyR2 by CaM (Balshaw et al., 2001). Addition of CaM to
the cis chamber reduced single-channel open probability (Po)
from 0.45 to 0.01. Elevation of cytosolic Ca21 from 2 to 100
mM increased Po from 0.45 to 0.90 (Fig. 1 B, upper trace).
Under this condition, CaM was less effective in inhibiting
single RyR2 channel activity (Fig. 1 B, lower trace). Fig. 1 C
summarizes the effects of CaM on Po at 0.15–100 mM
free cytosolic Ca21. Under steady-state conditions in the
presence of 5 mM reduced GSH and 5 mM MgATP, Po
increased from 0.0007 at 0.15 mM Ca21 to 0.7 at 100 mM
Ca21. CaM inhibition of RyR2 channel activity depended on
Ca21 concentration. CaM reduced the averaged Po 25-fold
from 0.25 to 0.01 at 2 mM cytosolic Ca21, compared to
a 1.25-fold decrease from 0.7 to 0.56 at 100 mM Ca21.
Analysis of single-channel recordings showed that at
cytosolic [Ca21] # 2 mM, CaM reduced channel open
probability by decreasing the number channel events and
mean open times and by increasing mean close times (Fig.
1 D). At 2 mMCa21, CaM decreased the average mean open
time 2.7-fold from 1.6 ms to 0.6 ms. The average mean close
time increased more than 10-fold from 13.6 to 146 ms. At
100 mM Ca21, CaM had a moderate effect on Po. Although
the average mean open time decreased ﬁvefold from 10 ms
to 2 ms, channel events increased fourfold. Taken together,
the data indicate that the effects of CaM on RyR2 ion chan-
nel opening and closing depend on the cytosolic Ca21
concentration.
The SR membrane is highly permeable to monovalent
cations and anions, which suggests that the SR membrane
potential in resting muscle is near 0 mV (Meissner, 1983).
The effects of CaM on RyR2 were therefore also determined
at 0 mV holding potential using 10 mM lumenal Ca21 as
current carrier. Fig. 2 (upper trace) shows a representative
RyR2 ion channel recording in which in the presence of 0.15
mM cytosolic Ca21 long channel closings were observed.
Addition of 1 mM CaM decreased Po ﬁvefold (Fig. 2, lower
trace). Table 1 summarizes the effects of 1 mM CaM on
single-channels recorded with 10 mMCa21 as current carrier
in the presence of 0.15 mM and 0.8 mM cytosolic Ca21. The
data suggest that CaM inhibited the channels by decreasing
the number of channel events and mean open times and
increasing the mean close times;\1 channel opening per 2 s
recording time was detected at 0.15 mM cytosolic Ca21.
Addition of 1 mM cytosolic CaM decreased this number to
\1 event per 5 s recording time. Thus CaM inhibited RyR2
independent of whether channels were activated by cytosolic
Ca21 or by way of lumenal-to-cytosolic Ca21 ﬂuxes.
Effects of CaM on RyR2 activated by open
channel-mediated lumenal Ca21 ﬂuxes
We used a voltage-pulse protocol to study the effects of CaM
on RyR2 ion channels that were activated by open channel-
mediated lumenal-to-cytosolic Ca21 ﬂuxes. The protocol
relied on the observation that lumenal Ca21 ﬂowing through
the open channel regulates channel activity by binding to
cytosolic Ca21 activating and inhibitory sites (Xu and
FIGURE 2 Effect of calmodulin on single cardiac SR Ca21 release
channel with Ca21 as current carrier. Cardiac SR vesicles were fused with
a lipid bilayer, and single-channel currents were recorded at 0 mV
(downward deﬂection from close levels, c--) in symmetric 0.25 M
CsCH3SO3, 10 mM Cs-Hepes, pH 7.3 media containing 5 mM cytosolic
GSH, 5 mMMgATP, and 0.15 mM cytosolic Ca21 in the absence (top trace)
and presence (bottom trace) of 1 mM CaM. Trans (SR lumenal) Ca21 was
10 mM.
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Meissner, 1998). In these studies we used proteoliposomes
containing the puriﬁed RyR2. Fusion of proteoliposomes
with the lipid bilayer yielded a stable baseline and small error
when subtracting the large capacitance currents occurring
during voltage pulses. Capacitance currents were obtained
from blank episodes that showed no channel currents. To
optimize the conditions for the measurement of RyR2 in
nonsteady-state conditions, the regulation of the puriﬁed
RyR2 by lumenal Ca21 and cytosolic CaM was ﬁrst
determined in steady-state conditions (Fig. 3). Channels
were recorded in 250 mM KCl on both sides of the bilayer
with 5 mM MgATP, 5 mM GSH, and 0.1 mM Ca21 in the
cis, cytosolic bilayer chamber, and 0.1 mM or 500 mM Ca21
in the trans, SR lumenal bilayer chamber. The cis chamber
also contained 10 mM caffeine to partially activate the
channels. Holding potentials of 50 mV and 150 mV were
used to yield open channel-mediated lumenal-to-cytosolic
Ca21 ﬂuxes of 1.7 pA and 0.02 pA, respectively, with 500
mM Ca21 in the lumenal bilayer chamber, as calculated
according to a barrier model that describes the ionic
conduction of the RyR2 (Tinker et al., 1992). Fig. 3 A
shows that with 0.1 mM Ca21 in the trans chamber, Po was
low and did not differ substantially at50 mV and150 mV.
In contrast, single-channel activities differed greatly at the
two holding potentials when the lumenal Ca21 concentration
was increased from 0.1 to 500 mM (Fig. 3 C). The average
single-channel activity increased by[50-fold from 0.004 6
0.002 at 150 mV to 0.2556 0.085 at 50 mV (n ¼ 7). The
RyR2 ion channel was signiﬁcantly inhibited by CaM at –50
mV and 150 mV with 0.1 mM Ca21 (Fig. 3, A and B) or
500 mM Ca21 (Fig. 3, C and D) in the trans chamber.
CaM increased close times and decreased open times
and number of channel events. Although small, a majority
of the differences were statistically signiﬁcant (Fig. 3, B
and D).
A representative RyR2 channel recording is shown in Fig.
4 using the voltage pulse protocol, 0.1 mM or 500 mM Ca21
in the trans bilayer chamber, and otherwise the conditions of
Fig. 3. A series of voltage pulses was applied to the bilayer
from 150 to 50 mV and from 50 mV to 150 mV (Fig.
4 A) to repeatedly vary lumenal-to-cytosolic Ca21 ﬂuxes and
thereby local cytosolic Ca21 concentration and RyR2
activity (Fig. 4 C). In the absence of CaM and presence of
500 mM lumenal Ca21, after a mean lag period of 100 6 4
ms (Fig. 4 D), voltage pulses from 150 mV to 50 mV
caused nearly full activation of the RyR2 ion channel (Fig.
4 C, upper single-channel current traces). The mean lag
period of channel opening signiﬁcantly increased to 1626 4
ms in the presence of 1 mM cytosolic CaM. In eight
recordings, the portion of episodes without channel openings
signiﬁcantly increased from 15.7 6 8.5% in the absence of
CaM to 28.0 6 9.0% in the presence of CaM. Long channel
openings or an increase in channel activity after a voltage
switch were not observed in the presence of 0.1 mM Ca21 in
the trans bilayer chamber (Fig. 4 B). Voltage pulses from
50 mV to 150 mV decreased the driving force of lumenal
Ca21 and reduced lumenal-to-cytosolic Ca21 ﬂuxes. In this
case with 500 mM Ca21 in the trans chamber, a prolonged
channel opening was observed immediately after the voltage
switch (Fig. 4 C, upper single-channel current traces).
Prolonged channel openings were only observed in episodes
that showed a long opening immediately before the voltage
switch. CaM (1 mM) signiﬁcantly decreased the mean open
time of these open events from 25.4 6 1.1 ms to 12.5 6 0.5
ms (Fig. 4 E). Subsequent channel events had open times that
were similar to those observed under steady-state conditions
(To ; 1–2 ms, Fig. 3 C). RyR2 channel activation or
inhibition showed no refractoriness when the duration of the
voltage pulses was varied from 150 ms to 1000 ms. Taken
together, results of Fig. 4 suggest that CaM shortens the
lifetimes of channel openings formed by lumenal-to-cyto-
solic Ca21 ﬂuxes.
To further delineate the Ca21 dependence of CaM
inhibition of RyR2, experiments were performed with
a non-Ca21 binding mutant of CaM (CaMD1234A, Keen
et al., 1999). The binding afﬁnity of the CaM mutant was
determined at 0.1 mM Ca21 by measuring its ability to
compete with 10–30 nM [35S]CaM for binding to RyR2
using an equilibrium displacement binding assay. The data
yielded a Kd value of 8206 224 nM (n ¼ 4). The functional
effects of the CaM mutant on RyR2 were explored in single-
channel recordings. We found that 2 mM CaMD1234A had no
effect on single RyR2 channel activities using assay
conditions identical to those of Figs. 1 A and 4.
TABLE 1 Effect of CaM on single-channel kinetic parameters with Ca21 as current carrier
0.15 mM Ca21 0.8 mM Ca21
CAM 1CaM CaM 1CaM
Po 0.00034 6 0.00014 0.00008 6 0.00002* 0.050 6 0.007 0.0006 6 0.0002*
Events/min 29 6 4 11 6 3* 163 6 32 32 6 12*
To (ms) 0.68 6 0.18 0.68 6 0.29 4.57 6 0.29 3.36 6 0.40*
Tc (ms) 2023 6 273 9103 6 3272 831 6 195 5579 6 1750*
Single-channel activities were determined as in Fig. 2 with 0.15 mM and 0.8 mM Ca21 in the cis chamber. Data are the mean 6 SE of 4–6 single-channel
recordings.
*p\ 0.05 compared to controls (CaM).
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DISCUSSION
This study shows that CaM inhibits Ca21 release channel
activity both when the channels are activated by cytosolic
Ca21 or by lumenal-to-cytosolic Ca21 ﬂuxes. At\10 mM
cytosolic Ca21, CaM decreased channel open probability by
decreasing the frequency of channel events and mean open
times and by increasing mean close times. At$10 mMCa21,
CaM was less effective in reducing channel activity, de-
creasing mean open times without affecting mean close
times. CaM delayed channel openings when luminal-to-
cytosolic Ca21 ﬂuxes were rapidly increased. In contrast,
channel closure was accelerated by CaM when lumenal-to-
cytosolic Ca21 ﬂuxes decreased.
RyR2 is activated by micromolar Ca21 concentrations and
inhibited by millimolar Ca21 concentrations, which suggests
the presence of high-afﬁnity activating and low-afﬁnity
FIGURE 3 Single-channel activities
and inhibition by CaM in 0.1 mM
lumenal Ca21 (A and B) and 500 mM
lumenal Ca21 (C and D). Proteolipo-
somes containing puriﬁed RyR2 were
fused with a lipid bilayer. Single-
channel currents were recorded at –50
mV (left panels) and 150 mV (right
panels) in symmetric 0.25 M KCl
media with 5 mM cytosolic GSH,
5 mM MgATP, 10 mM caffeine (an
activator of the Ca21 release channel),
and 0.1 mM Ca21 with either 0.1 mM
lumenal Ca21 (A) or 500 mM lumenal
Ca21 (C) in the absence (top traces)
and presence (bottom traces) of 1 mM
CaM. (B) Normalized Po values, num-
ber of channel events, and mean open
(To) and close (Tc) times at 50 mV
and 150 mV for A. Averaged control
parameters (CaM) were in (A) at 50
mV: Po ¼ 0.002 6 0.001, events/min
¼ 174 6 109, To ¼ 1.41 6 0.17 ms,
Tc ¼ 2381 6 1233 ms; at 150 mV:
Po ¼ 0.008 6 0.003, events/min ¼
4356 166, To ¼ 1.356 0.26 ms. Tc ¼
11106 756ms. (D) Normalized param-
eters for C. Averaged control param-
eters (CaM) for C were at 50 mV:
Po ¼ 0.255 6 0.085, events/min ¼
431 6 233, To ¼ 134 6 51 ms, Tc ¼
1167 6 627 ms; at 150 mV: Po ¼
0.00460.002,events/min¼1796100,
To¼ 2.136 0.44 ms, Tc¼ 13166 325
ms. Data are the mean 6 SE of seven
experiments. *p \ 0.05 and **p \
0.001 compared to normalized data in
the absence of CaM.
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inhibitory Ca21 binding sites (Franzini-Armstrong and
Protasi, 1997; Fill and Copello, 2002; Meissner, 2002).
Both types of Ca21 binding sites are accessible from the
cytosolic side in the large cytosolic foot region of RyRs.
Single-channel measurements show that SR lumenal Ca21
also regulates RyR2 by binding to lumenal channel sites
(Sitsapesan and Williams, 1997; Gyorke and Gyorke, 1998)
or by gaining access to cytosolic Ca21 activation and
inhibition sites after passage to the cytosolic receptor side
(Xu and Meissner, 1998). Ca21-gated RyR2 ion channel
activity is modulated by allosteric factors such as protein
phosphorylation, MgATP, redox active molecules, and CaM
(Franzini-Armstrong and Protasi, 1997; Fill and Copello,
2002; Meissner, 2002). In this study, single-channel record-
ings were performed in the presence of MgATP and reduced
GSH. In the presence of the two endogenous effector
molecules, CaM affected the Ca21 dependence of [3H]rya-
nodine binding similarly as in this study (Balshaw et al.,
2001). However, the [3H]ryanodine binding studies lacked
the detailed kinetic information provided by the single-
channel measurements of this study.
The results of this study support a previously proposed
model (Xu and Meissner, 1998) in which lumenal Ca21 can
activate the puriﬁed RyR2 only when the channel is open.
Activation requires initial channel opening so that lumenal
Ca21 can gain access to the cytosolic regulatory Ca21 sites.
Therefore, the delay after a change in holding potential from
150 mV to –50 mV reﬂected the fact that at the positive
holding potential, channels opened infrequently under the
conditions used in this study. CaM delayed channel acti-
vation by decreasing the frequency of channel openings, as
determined in steady-state conditions, which suggests that
CaM may affect the occurrence of cellular Ca21 release
events called Ca21 sparks that arise from the spontaneous
openings of RyR2s. However, it should be noted that the
activating conditions used in this study are not the same as
those during a cardiac action potential in cardiomyocytes.
Rather than by SR lumenal Ca21, cardiac SR Ca21 release
is triggered by Ca21 ions that enter the cells by way of the
L-type Ca21 channel.
Ca21 gradients formed by lumenal-to-cytosolic Ca21
ﬂuxes dissipate within ;100 ms as channels close (Simon
and Llinas, 1985; Stern, 1992). One would have then ex-
pected that channels closed rapidly as the lumenal-to-
cytosolic Ca21 ﬂux was reduced by a voltage change from
50 mV to150 mV. However, the open events immediately
after the voltage switch were much longer than those at 150
mV in steady-state conditions. Thus, a prolonged lumenal to
cytosolic Ca21 ﬂux preceding the voltage switch appeared to
affect the time course of channel closure without eliminating
FIGURE 4 Regulation of RyR2 by
CaM using a rapid voltage pulse pro-
tocol. A representative puriﬁed RyR2
ion channel recording in the absence
and presence of 1mM cisCaM in a 0.25
M KCl, pH 7.4 medium that contained
0.1 mM free Ca21, 10 mM caffeine, 5
mM GSH, and 5 mM MgATP in the
cytosolic (cis) chamber, and 0.1 mM
(B) or 500 mM (C) Ca21 in the SR
lumenal (trans) chamber. (A) A series
of 300 voltage pulses from1 50 mV to
50 mV and from 50 mV to 150
mV was applied to the bilayer to
increase and reduce open channel-
mediated lumenal to cytosolic Ca21
ﬂuxes, respectively. (B) Three episodes
in the presence of 0.1 mM trans Ca21
without added CaM are shown. (C)
Three episodes each of channel cur-
rents in the presence of 500 mM trans
Ca21 without (upper current traces)
and with 1 mM CaM (lower current
traces) are shown. Channel openings
are shown as downward (50 mV) or
upward (150 mV) deﬂections from
close levels (marked c). (D) Mean
times it took to observe the ﬁrst
channel opening after the voltage
switch from 150 mV to 50 mV in
the absence and presence of 1 mM
CaM. Data are the mean 6 SE of 1264
(CaM) and 1169 (1CaM) episodes
of eight recordings. (E) Mean open times of single-channel events immediately after the voltage switch from50 mV to150 mV in the absence and presence
of 1 mM CaM. Data are the mean 6 SE of 895 (CaM) and 648 (1CaM) episodes of eight recordings. *p\ 0.05 compared to controls (CaM).
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CaM inhibition. CaM binds to and is released from RyR2
within seconds to minutes. Therefore, CaM affected channel
activity by remaining constitutively bound to RyR2. In-
hibition appeared to depend on the binding of Ca21-sensitive
CaM because a non-Ca21 binding mutant of CaM was
without effect.
During a cardiac action potential, Ca21 ions entering the
cell via the L-type Ca21 channel trigger the release of
massive amounts of Ca21 from the SR via the RyR2 and the
release of Ca21 triggers further Ca21 release. Such a high-
gain, positive feedback system is potentially unstable,
resulting in a none-or-all response. Several mechanisms
have been proposed for ending Ca21 release from SR. First,
Ca21- and time-dependent inactivation terminates SR Ca21
release (Fabiato, 1985). This inactivation mechanism is
challenged by single-channel and SR vesicle Ca21 ﬂux
measurements that show no Ca21- or time-dependent in-
hibition except a Ca21-dependent inhibition at nonphysio-
logical Ca21 concentrations[1 mM (Rousseau et al., 1986).
Second, Ca21 release is terminated because the supply of
releasable Ca21 in the SR is exhausted. This mechanism
requires ‘‘local’’ depletion of SR Ca21 because substantial
amounts of Ca21 remain within the SR after a Ca21 transient
(Bassani et al., 1995; Negretti et al., 1995; Chen et al., 1998).
However, as recently reported, Ca21 ions rapidly diffuse
from the free to junctional SR (Shannon et al., 2003). It is
therefore unlikely that Ca21 release is limited by SR Ca21
availability. A third mechanism is that when the L-type Ca21
channel closes, SR Ca21 release is terminated locally
through ‘‘stochastic attrition’’ (Stern, 1992). Modeling stud-
ies have shown that the simultaneous stochastic closing of
a cluster of closely apposed release channels can reduce
the local cytosolic Ca21 concentration to a subthreshold
level, thereby ending SR Ca21 release (Stern, 1992; Sobie
et al., 2002). RyR2s are organized in release units of ;100
release channels depending on the species (Franzini-
Armstrong et al., 1999), which if all are activated would
require the simultaneous closing of a large number of
channels, however, as few as 4–6 ryanodine receptors may
sufﬁce to trigger a Ca21 release event (Ca21 spark) (Wang
et al., 2001). In support of a simultaneous closing, Marx et al.
(2001) have reported that RyR2 ion channels display
synchronized openings and closings in lipid bilayers
(coupled gating). The results of this study suggest that
CaM may facilitate termination of SR Ca21 release when the
local activator Ca21 concentration decreases to ;10 mM by
a mechanism that remains to be resolved. We offer the
following model. Our data suggest that during diastole at
a myoplasmic Ca21 concentration of ;100 nM, the binding
of CaMmaintains the RyR2 in a close state. During an action
potential, inﬂux of Ca21 via the L-type Ca21 channel rapidly
raises the Ca21 concentration at the Ca21 release sites to
submillimolar values, resulting in the activation of the RyR2.
During the initial release phase, SR Ca21 release is little
affected by CaM because of a high local Ca21 activator
concentration that is formed by Ca21 ions that both enter the
cell and are released by the SR. On the other hand, our in
vitro observations suggest that CaM may have a role in
the termination of SR Ca21 release by reducing the release
of Ca21 ions when the local activator Ca21 concentration
decreases to;10 mM, with maximal effects observed at low
micromolar to submicromolar Ca21 concentrations. CaM
increasingly prolongs the close channel times as the Ca21
concentration decreases, allowing Ca21 more time to diffuse
away from the release sites and thereby reducing the
probability of channel reopening.
CaM is likely only one of several factors that may have
a role in the termination of SR Ca21 release. Other proteins
reported to affect SR Ca21 release include calsequestrin
(Szegedi et al., 1999), sorcin (Farrell et al., 2003; Seidler
et al., 2003), and S100 (Most et al., 2003). Furthermore,
CaM acts on other proteins that regulate SR Ca21 release
such as the sarcolemmal voltage dependent Ca21 channel
(DHPR), calmodulin dependent protein kinase (CaMKII),
and calmodulin stimulated protein phosphatase (calcineurin)
(Anderson, 2002).
In conclusion, our single-channel measurements provide
the ﬁrst detailed kinetic examination of the regulation of the
Ca21-gated cardiac Ca21 release channel by CaM. CaM
provides a complementary mechanism of regulating SR
Ca21 release, in addition to the regulation of RyR2 by Ca21.
Our in vitro observations support a model in which the action
of CaM in ending SR Ca21 release is facilitatory. CaM
lowers RyR2-mediated SR Ca21 release at low micromolar
to submicromolar Ca21 concentrations by decreasing the
number of channel events and increasing the duration of
close times. Deciphering the kinetics of channel opening and
closing associated with the inhibition of the cardiac Ca21
release channel by one of its endogenous effectors should
help to elucidate the not well-understood mechanism of SR
Ca21 release in the myocardium.
The authors thank Daniel A. Pasek for preparing the cardiac SR vesicles
and for purifying the RyR2.
This work was supported by National Institutes of Health grants HL27430
and HL73051.
REFERENCES
Anderson, M. E. 2002. Calmodulin and the philosopher’s stone: Changing
Ca21 into arrhythmias. J. Cardiovasc. Electrophysiol. 13:195–197.
Balshaw, D. M., L. Xu, N. Yamaguchi, D. A. Pasek, and G. Meissner.
2001. Calmodulin binding and inhibition of cardiac muscle calcium
release channel (ryanodine receptor). J. Biol. Chem. 276:20144–20153.
Balshaw, D. M., N. Yamaguchi, and G. Meissner. 2002. Modulation of
intracellular calcium-release channels by calmodulin. J. Membr. Biol.
185:1–8.
Bassani, J. W., W. Yuan, and D. M. Bers. 1995. Fractional SR Ca release is
regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J.
Physiol. 268:C1313–C1319.
Calmodulin Inhibition of RyR2 803
Biophysical Journal 86(2) 797–804
Chen, W., R. London, E. Murphy, and C. Steenbergen. 1998. Regulation of
the Ca21 gradient across the sarcoplasmic reticulum in perfused rabbit
heart. A 19F nuclear magnetic resonance study. Circ. Res. 83:898–907.
Fabiato, A. 1985. Time and calcium dependence of activation and
inactivation of calcium-induced release of calcium from the sarcoplasmic
reticulum of a skinned canine cardiac Purkinje cell. J. Gen. Physiol.
85:247–289.
Farrell, E. F., A. Antaramian, A. Rueda, A. M. Go´mez, and H. H. Valdivia.
2003. Sorcin inhibits calcium release and modulates excitation-
contraction coupling in the heart. J. Biol. Chem. 278:34660–34666.
Fill, M., and J. A. Copello. 2002. Ryanodine receptor calcium release
channels. Physiol. Rev. 82:893–922.
Franzini-Armstrong, C., and F. Protasi. 1997. Ryanodine receptors of
striated muscles: a complex channel capable of multiple interactions.
Physiol. Rev. 77:699–729.
Franzini-Armstrong, C., F. Protasi, and V. Ramesh. 1999. Shape, size, and
distribution of Ca21 release units and couplons in skeletal and cardiac
muscle. Biophys. J. 77:1528–1539.
Gyorke, I., and S. Gyorke. 1998. Regulation of the cardiac ryanodine
receptor channel by luminal Ca21 involves luminal Ca21 sensing sites.
Biophys. J. 75:2801–2810.
Keen, J. E., R. Khawaled, D. L. Farrens, T. Neelands, A. Rivard, C. T.
Bond, A. Janowsky, B. Fakler, J. P. Adelman, and J. J. Maylie. 1999.
Domains responsible for constitutive and Ca21-dependent interactions
between calmodulin and small conductance Ca21-activated potassium
channels. J. Neurosci. 19:8830–8838.
Lee, H. B., L. Xu, and G. Meissner. 1994. Reconstitution of the skeletal
muscle ryanodine receptor-Ca21 release channel protein complex into
proteoliposomes. J. Biol. Chem. 269:13305–13312.
Luo, C. H., and Y. Rudy. 1994. A dynamic model of the cardiac ventricular
action potential. I. Simulations of ionic currents and concentration
changes. Circ. Res. 74:1071–1096.
Marx, S. O., J. Gaburjakova, M. Gaburjakova, C. Henrikson, K. Ondrias,
and A. R. Marks. 2001. Coupled gating between cardiac calcium release
channels (ryanodine receptors). Circ. Res. 88:1151–1158.
Meissner, G. 1983. Monovalent ion and calcium ion ﬂuxes in sarcoplasmic
reticulum. Mol. Cell. Biochem. 55:65–82.
Meissner, G. 2002. Regulation of mammalian ryanodine receptors. Front.
Biosci. 7:d2072–d2080.
Most, P., A. Remppis, S. T. Pleger, E. Lo¨fﬂer, P. Ehlermann, J. Bernotat, C.
Kleuss, J. Heierhorst, P. Ruiz, H. Witt, P. Karczewski, L. Mao, H. A.
Rockman, S. J. Duncan, H. A. Katus, and W. J. Koch. 2003. Transgenic
overexpression of the Ca21-binding protein S100A1 in the heart leads to
increased in vivo myocardial contractile performance. J. Biol. Chem.
278:33809–33817.
Negretti, N., A. Varro, and D. A. Eisner. 1995. Estimate of net calcium
ﬂuxes and sarcoplasmic reticulum content during systole in rat
ventricular myocytes. J. Physiol. (Lond.). 486:581–591.
Rhoads, A. R., and F. Friedberg. 1997. Sequence motifs for calmodulin
recognition. FASEB J. 11:331–340.
Rousseau, E., J. S. Smith, J. S. Henderson, and G. Meissner. 1986. Single
channel and 45Ca21 ﬂux measurements of the cardiac sarcoplasmic
reticulum calcium channel. Biophys. J. 50:1009–1014.
Schoenmakers, J. M., G. J. Visser, G. Flick, and A. P. R. Theuvene. 1992.
CHELATOR: an improved method for computing metal ion concen-
trations in physiological solutions. Biotechniques. 12:870–879.
Seidler, T., S. L. Miller, C. M. Loughrey, A. Kania, A. Burow, S.
Kettlewell, N. Teucher, S. Wagner, H. Kogler, M. B. Meyers, G.
Hasenfuss, and G. L. Smith. 2003. Effects of adenovirus-mediated sorcin
overexpression on excitation-contraction coupling in isolated rabbit
cardiomyocytes. Circ. Res. 25:132–139.
Shannon, T. R., T. Guo, and D. M. Bers. 2003. Ca21 scraps. Local
depletions of free [Ca21] in cardiac sarcoplasmic reticulum during
contractions leave substantial Ca21 reserve. Circ. Res. 93:40–45.
Simon, S. M., and R. R. Llinas. 1985. Compartmentalization of the
submembrane activity during calcium inﬂux and its signiﬁcance in
transmitter release. Biophys. J. 48:485–498.
Sitsapesan, R., and A. J. Williams. 1997. Regulation of current ﬂow
through ryanodine receptors by luminal Ca21. J. Membr. Biol. 159:179–
185.
Sobie, E. A., K. W. Dilly, J. dos Santos Cruz, W. J. Lederer, and M. S.
Jafri. 2002. Termination of cardiac Ca21 sparks: an investigative
mathematical model of calcium-induced calcium release. Biophys. J. 83:
59–78.
Stern, M. D. 1992. Theory of excitation-contraction coupling in cardiac
muscle. Biophys. J. 63:497–517.
Szegedi, C., S. Sarkozi, A. Herzog, I. Jona, and M. Varsanyi. 1999.
Calsequestrin: more than only a luminal Ca21 buffer inside the
sarcoplasmic reticulum. Biochem. J. 337:19–22.
Tinker, A., A. R. Lindsay, and A. J. Williams. 1992. A model for ionic
conduction in the ryanodine receptor channel of sheep cardiac muscle
sarcoplasmic reticulum. J. Gen. Physiol. 100:495–517.
Wang, S. Q., L. S. Song, E. G. Lakatta, and H. Cheng. 2001. Ca21
signalling between single L-type Ca21 channels and ryanodine receptors
in heart cells. Nature. 410:592–596.
Yamaguchi, N., L. Xu, D. A. Pasek, K. E. Evans, and G. Meissner. 2003.
Molecular basis of calmodulin binding to cardiac muscle Ca21 release
channel (ryanodine receptor). J. Biol. Chem. 278:23480–23486.
Xu, L., and G. Meissner. 1998. Regulation of cardiac muscle Ca21 release
channel by sarcoplasmic reticulum lumenal Ca21. Biophys. J. 75:2302–
2312.
804 Xu and Meissner
Biophysical Journal 86(2) 797–804
